Investors and Media

Press Releases

September 10, 2024

Scholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in Obesity

September 4, 2024

Scholar Rock Appoints Beth Shafer, Ph.D., to Chief Business Officer

August 29, 2024

Scholar Rock to Participate in Upcoming Investor Conferences

August 16, 2024

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 8, 2024

Scholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business Progress

July 23, 2024

Scholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

July 12, 2024

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 24, 2024

Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal

Archived Press Releases